Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease

Bariatric surgery remains a potent therapy for nonalcoholic fatty liver disease (NAFLD), but its inherent risk and eligibility requirement limit its adoption. Therefore, understanding how bariatric surgery improves NAFLD is paramount to developing novel therapeutics. Here, we show that the microbiom...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Tien S., Katzka, William, Yang, Julianne C., Chang, Candace, Arias-Jayo, Nerea, Lagishetty, Venu, Balioukova, Anna, Chen, Yijun, Dutson, Erik, Li, Zhaoping, Mayer, Emeran A., Pisegna, Joseph R., Sanmiguel, Claudia, Jacobs, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897796/
https://www.ncbi.nlm.nih.gov/pubmed/36732495
http://dx.doi.org/10.1080/19490976.2023.2167170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897796/
https://www.ncbi.nlm.nih.gov/pubmed/36732495
http://dx.doi.org/10.1080/19490976.2023.2167170

Ejemplares similares